Status:
COMPLETED
Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org
Lead Sponsor:
Royal Free Hospital NHS Foundation Trust
Collaborating Sponsors:
Seoul National University Bundang Hospital
Cancer Institute Hospital, Japan
Conditions:
Pancreatic Neoplasms
Pancreaticoduodenectomy
Eligibility:
All Genders
18+ years
Brief Summary
The WhippleBenchmark 2 Collaborative study aims at defining benchmark criteria for best achievable outcomes after pancreaticoduodenectomy with portal vein resection.
Detailed Description
Pancreatoduodenectomy (PD) with portal vein resection (PVR) is performed for the achievement of complete resection (R0) in patients with locally advanced pancreatic head lesions. Despite most commonly...
Eligibility Criteria
Inclusion
- Center Eligibility Criteria
- High volume centers from ≥3 continents
- Minimum 50 cases of pancreatic surgery per year or 150 cases within 3 years
- Published in the area of pancreas surgery
- Prospective database available
- Patient Eligibility Criteria
- Adults ≥ 18 years
- Resectable malignant or benign diseases (i.e. all indications)
- Open pancreaticoduodenectomy (all techniques allowed) with concurrent portal vein resection
Exclusion
- Patients \< 18 years
- Pancreatic resections other than pancreaticoduodenectomy and portal vein resection
- Pancreaticoduodenectomy with arterial reconstruction
- Laparoscopic or robotic pancreaticoduodenectomy
Key Trial Info
Start Date :
August 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
1462 Patients enrolled
Trial Details
Trial ID
NCT04053998
Start Date
August 9 2019
End Date
February 20 2020
Last Update
November 20 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Parc de Salut Mar
Barcelona, Spain, 08003
2
Royal Free Hospital
London, United Kingdom, NW3 2QG